Can CRISPR gene editing therapy be scaled globally?

CRISPR gene editing therapy Impact on Science by 2026

The science industry is undergoing significant transformation driven by crispr gene editing therapy.

Key challenges include scaling infrastructure, managing transition risks, and ensuring broad accessibility.

If this forecast materializes, it would demonstrate crispr gene editing therapy has achieved critical mass and market acceptance.